A new alternative to Botox® and Dysport will be showing up in dermatologists’ offices soon, as the FDA recently approved the use of Xeomin. Xeomin is an injection that, like Botox® , consists of the botulinum toxin. After two separate trials testing the drug or a placebo on over 500 participants, the FDA decided that Xeomin was a safe, effective temporary treatment for forehead wrinkles.
Though Xeomin injections are new to the US, they have been approved and used in several European countries. There are only minor distinctions between the new product and Botox® : for example, Xeomin doesn’t require refrigeration. Also, Xeomin lacks a protein coating that Botox® has. A small number of patients develop antibodies to the protein, so for those individuals, Xeomin will be a more effective treatment.
The effect that Xeomin will have on Botox® and Dysport remains to be seen. Since Botox® is a more trusted name in cosmetic dermatology, Xeomin will have to prove itself as an inexpensive, effective, and long-lasting treatment. To discuss cosmetic dermatology options, contact Dr. Zimmet today.